The global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area

North American market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy include Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics，Ltd, Juno Therapeutics, Kite Pharma, Atara Biotherapeutics, Carina Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy.

The Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Report

Report Metric	Details
Report Name	Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
Segment by Type	Allogeneic CAR T-Cells Autologous CAR T-Cells
Segment by Application	Hospital Diagnostic Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics，Ltd, Juno Therapeutics, Kite Pharma, Atara Biotherapeutics, Carina Biotech, Guangzhou Xiangxue Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market report?

Ans: The main players in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market are Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics，Ltd, Juno Therapeutics, Kite Pharma, Atara Biotherapeutics, Carina Biotech, Guangzhou Xiangxue Pharmaceutical

What are the Application segmentation covered in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market report?

Ans: The Applications covered in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market report?

Ans: The Types covered in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market report are Allogeneic CAR T-Cells, Autologous CAR T-Cells

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Allogeneic CAR T-Cells

1.2.3 Autologous CAR T-Cells

1.3 Market by Application

1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Perspective (2020-2031)

2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Growth Trends by Region

2.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Dynamics

2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Trends

2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers

2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges

2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue

3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue

3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio

3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2024

3.5 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Head office and Area Served

3.6 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, Product and Application

3.7 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Type

4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031)

5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Application

5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2020-2031)

6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025)

6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2020-2031)

7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025)

7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2020-2031)

9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.1.4 Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.2.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Bristol Myers Squibb

11.3.1 Bristol Myers Squibb Company Details

11.3.2 Bristol Myers Squibb Business Overview

11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.3.4 Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.3.5 Bristol Myers Squibb Recent Development

11.4 Legend Biotech

11.4.1 Legend Biotech Company Details

11.4.2 Legend Biotech Business Overview

11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.4.4 Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.4.5 Legend Biotech Recent Development

11.5 Sorrento Therapeutics

11.5.1 Sorrento Therapeutics Company Details

11.5.2 Sorrento Therapeutics Business Overview

11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.5.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.5.5 Sorrento Therapeutics Recent Development

11.6 CARSGEN Therapeutics，Ltd

11.6.1 CARSGEN Therapeutics，Ltd Company Details

11.6.2 CARSGEN Therapeutics，Ltd Business Overview

11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.6.4 CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.6.5 CARSGEN Therapeutics，Ltd Recent Development

11.7 Juno Therapeutics

11.7.1 Juno Therapeutics Company Details

11.7.2 Juno Therapeutics Business Overview

11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.7.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.7.5 Juno Therapeutics Recent Development

11.8 Kite Pharma

11.8.1 Kite Pharma Company Details

11.8.2 Kite Pharma Business Overview

11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.8.4 Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.8.5 Kite Pharma Recent Development

11.9 Atara Biotherapeutics

11.9.1 Atara Biotherapeutics Company Details

11.9.2 Atara Biotherapeutics Business Overview

11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.9.4 Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.9.5 Atara Biotherapeutics Recent Development

11.10 Carina Biotech

11.10.1 Carina Biotech Company Details

11.10.2 Carina Biotech Business Overview

11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.10.4 Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.10.5 Carina Biotech Recent Development

11.11 Guangzhou Xiangxue Pharmaceutical

11.11.1 Guangzhou Xiangxue Pharmaceutical Company Details

11.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview

11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction

11.11.4 Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

11.11.5 Guangzhou Xiangxue Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sorrento Therapeutics

CARSGEN Therapeutics，Ltd

Juno Therapeutics

Kite Pharma

Atara Biotherapeutics

Carina Biotech

Guangzhou Xiangxue Pharmaceutical

List of Tables

Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Allogeneic CAR T-Cells

Table 3. Key Players of Autologous CAR T-Cells

Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2020-2025)

Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2026-2031)

Table 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends

Table 11. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers

Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges

Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

Table 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players (2020-2025)

Table 16. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2024)

Table 17. Ranking of Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, Headquarters and Area Served

Table 20. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, Product and Application

Table 21. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2020-2025)

Table 25. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2026-2031)

Table 27. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2020-2025)

Table 29. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2026-2031)

Table 31. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 49. Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 54. Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Bristol Myers Squibb Company Details

Table 57. Bristol Myers Squibb Business Overview

Table 58. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 59. Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 60. Bristol Myers Squibb Recent Development

Table 61. Legend Biotech Company Details

Table 62. Legend Biotech Business Overview

Table 63. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 64. Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 65. Legend Biotech Recent Development

Table 66. Sorrento Therapeutics Company Details

Table 67. Sorrento Therapeutics Business Overview

Table 68. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 69. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 70. Sorrento Therapeutics Recent Development

Table 71. CARSGEN Therapeutics，Ltd Company Details

Table 72. CARSGEN Therapeutics，Ltd Business Overview

Table 73. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 74. CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 75. CARSGEN Therapeutics，Ltd Recent Development

Table 76. Juno Therapeutics Company Details

Table 77. Juno Therapeutics Business Overview

Table 78. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 79. Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 80. Juno Therapeutics Recent Development

Table 81. Kite Pharma Company Details

Table 82. Kite Pharma Business Overview

Table 83. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 84. Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 85. Kite Pharma Recent Development

Table 86. Atara Biotherapeutics Company Details

Table 87. Atara Biotherapeutics Business Overview

Table 88. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 89. Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 90. Atara Biotherapeutics Recent Development

Table 91. Carina Biotech Company Details

Table 92. Carina Biotech Business Overview

Table 93. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 94. Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 95. Carina Biotech Recent Development

Table 96. Guangzhou Xiangxue Pharmaceutical Company Details

Table 97. Guangzhou Xiangxue Pharmaceutical Business Overview

Table 98. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product

Table 99. Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 100. Guangzhou Xiangxue Pharmaceutical Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Picture

Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Allogeneic CAR T-Cells Features

Figure 5. Autologous CAR T-Cells Features

Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Diagnostic Center Case Studies

Figure 10. Others Case Studies

Figure 11. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered

Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region: 2024 VS 2031

Figure 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players in 2024

Figure 16. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2024

Figure 18. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 20. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 24. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2020-2031)

Figure 32. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 40. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 44. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 49. Bristol Myers Squibb Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 50. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 51. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 52. CARSGEN Therapeutics，Ltd Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 53. Juno Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 54. Kite Pharma Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 55. Atara Biotherapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 56. Carina Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 57. Guangzhou Xiangxue Pharmaceutical Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions